About: Richard Gilson

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Richard Gilson Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) 研究者 (ja) araştırmacı (tr) дослідник (uk) изилдөөчү (ky) հետազոտող (hy) onderzoeker (nl)
rdfs:label	Richard Gilson (en) Richard Gilson (es) Richard Gilson (it) Richard Gilson (nl) Richard Gilson (ast)
skos:prefLabel	Richard Gilson (en) Richard Gilson (es) Richard Gilson (it) Richard Gilson (nl) Richard Gilson (ast)
name	Richard Gilson (en) Richard Gilson (es) Richard Gilson (it) Richard Gilson (nl) Richard Gilson (ast)
ResearchGate contributions ID	wds:Q62006744-01466da5-4e36-689d-2b64-8540eed031b0
ResearchGate contributions ID	39509593
given name	wds:Q62006744-3E517579-2A51-4B60-9CE5-7FDE1FC0B697 wds:Q62006744-f259dc1d-4681-6085-e231-5472e9c56bb3
given name	Richard John
instance of	wds:Q62006744-68C04B1D-74A6-4CB8-84DF-F79678EC7242
instance of	Homo sapiens
skos:altLabel	Richard J. Gilson (en) Richard John Gilson (en)
occupation	wds:Q62006744-77F9DCF6-C672-40A1-9DAF-E52E430C23FA
employer	wds:Q62006744-1CE746C2-EFCF-42D6-B4D1-0F655A1B6691
sex or gender	wds:Q62006744-E2715C17-DD34-472F-ADC3-BFAE23AD81C3
family name	wds:Q62006744-0e0f88f8-4c50-c319-0229-27b0476f0390
official website	wds:Q62006744-8DD6A164-6C9F-4A0D-9B63-23F24A7D0B7C
occupation	researcher
employer	University College London
sex or gender	male
family name	Gilson
official website	http://iris.ucl.ac.uk/iris/browse/profile?upi=RJCGI10
ORCID iD	wds:Q62006744-5B3556A2-C9AA-4999-B6E7-E5C72934514C
Dimensions author ID	wds:Q62006744-ECA90EE6-7DA2-4866-8DB2-886C3E0A07AA
ORCID iD	https://orcid.org/0000-0002-9572-193X
ORCID iD	0000-0002-9572-193X
Dimensions author ID	0700663240.28
Gateway to Research person ID	wds:Q62006744-9FA81C7E-2A2D-40E4-826D-1B0754DAED12
Gateway to Research person ID	626392FD-F63C-452E-B6B3-C5B85ED84586
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q62006744
is author of	Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice Systematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure A Cross-Sectional Study on Attitudes to and Understanding of Risk of Acquisition of HIV: Design, Methods and Participant Characteristics Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication. Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study Interpretation of lung function tests in the sickle-cell haemoglobinopathies Data linkage reduces loss to follow-up in an observational HIV cohort study Factors influencing lopinavir and atazanavir plasma concentration Virological response to initial antiretroviral regimens containing abacavir or tenofovir. Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring Similarity in males and females of HDL2 and HDL3 cholesterol concentration in a caribbean rural community Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures BHIVA Guidelines: coinfection with HIV and Chronic hepatitis B virus Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study). Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. Hepatitis B, hepatitis C and mortality among HIV-positive individuals No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals Hepatitis B serological markers and plasma DNA concentrations Performance of human papillomavirus DNA detection in residual specimens taken for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoeae</i> nucleic acid amplification testing in men who have sex with men The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations The Context of Sexual Risk Behaviour Among Men Who Have Sex with Men Seeking PrEP, and the Impact of PrEP on Sexual Behaviour Obesity in women living with HIV aged 45–60 in England: An analysis of the PRIME study Follicle‐stimulating hormone in postmenopausal women living with HIV: a prevalence study 2019 IUSTI-Europe guideline for the management of anogenital warts A highly virulent variant of HIV-1 circulating in the Netherlands Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of r Menopausal status, age and management among women living with HIV in the UK New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings
is author of	wds:Q28484920-2AB1A4ED-7484-4C25-AF02-72461A70FC15 wds:Q35316315-D530E3C1-A334-484D-B0D1-8B5B9F231C68 wds:Q51654249-6A0C95CF-C92E-42E5-9113-1818BA73633B wds:Q45918855-490C7632-1F72-431A-8101-01D8FA7759E7 wds:Q28533767-99B9FF1F-6A85-4BDD-B916-2EA28134E9A0 wds:Q35111092-43FED85B-CCAD-4184-ABFE-8B7570D06B04 wds:Q45711101-78887FE3-9DBE-41F2-91E3-DA0D640DB2C2 wds:Q34847029-E4DA6EE2-1D3C-4A08-876D-1B2C5563A803 wds:Q37476403-1A43D9E7-EEC6-490A-8B55-F62C621C49EF wds:Q45306004-2D8A79FA-55E3-4281-B06C-2965BC2B58D7

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software